MeiraGTx advances gene therapy initiative for Parkinson disease patients

Traders Union
All News
Companies
MeiraGTx launches Parkinson gene therapy

Top Stories

Editors' Picks

Stocks

Crypto

Financial News

Currencies

Commodities

Companies

Central Banks

11.04.2026

MeiraGTx advances gene therapy initiative for Parkinson disease patients — MeiraGTx launches Parkinson gene therapy

MeiraGTx announced its commitment to improving care for individuals affected by Parkinson disease through its AAV-GAD program.

The company expressed gratitude on World Parkinsons Day to patients, caregivers, and advocates who inspire their research efforts. MeiraGTx aims to address critical gaps in current treatment options with innovative gene therapy approaches targeting the underlying causes of the disease.

Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.

Did you like the article?

Editor's Picks for You

Bitcoin price prediction and Bollinger Bands: Can BTC recover after falling to $63,000?

By Mikhail Vnuchkov
19 hours ago

Bitcoin price prediction and Bollinger Bands: Can BTC recover after falling to $63,000?

Editors' Picks

FIFA World Cup on blockchain: Where football meets crypto

By Oleg Tkachenko
Yesterday

FIFA World Cup on blockchain: Where football meets crypto

Editors' Picks

Aliens, Satoshi, and Bitcoin: How the extraterrestrial theory emerged

By Pavlo Kot
21.06.2026

Aliens, Satoshi, and Bitcoin: How the extraterrestrial theory emerged

Editors' Picks

All Editors' Top Picks

Latest MeiraGTx News

MeiraGTx joins Chardan conference to discuss genetic medicine advances

By Viktoras Karapetjanc
20.10.2025

MeiraGTx joins Chardan conference to discuss genetic medicine advances

Market Voices

MeiraGTx platform boosts gene therapy efficiency with AI-driven promoter activity

By Dmytro Kharkov
17.10.2025

MeiraGTx platform boosts gene therapy efficiency with AI-driven promoter activity

Market Voices

MeiraGTx advances Parkinsons gene therapy with RMAT approval

By Olga Shendetskaya
14.10.2025

MeiraGTx advances Parkinsons gene therapy with RMAT approval

Market Voices

All MeiraGTx News

Mikhail Vnuchkov
19 hours ago

Bitcoin price prediction and Bollinger Bands: Can BTC recover after falling to $63,000?

Oleg Tkachenko
Yesterday

FIFA World Cup on blockchain: Where football meets crypto

Pavlo Kot
21.06.2026

Aliens, Satoshi, and Bitcoin: How the extraterrestrial theory emerged

Pavlo Kot
20.06.2026

Blockchain nation in crisis: How a power struggle split Liberland

Eugene Komchuk
19.06.2026

Shifting priorities: Governments back mining as businesses turn to AI

Eugene Komchuk
13 min ago

Domestic policy choices shaped financialization shift, Michael Green notes

Olga Shendetskaya
13 min ago

Wendy O: Trump calls stock buybacks a fake strategy for raising prices

Andrey Mastykin
33 min ago

Anna Wong: Clear communication on inflation is essential

Ashutosh Sureka
48 min ago

Bill Pulte: Fannie Mae expanding pilot to reduce title insurance costs for refinancings

Daria Chernytska
1 hour ago

Free banking depends on having a base standard, George Selgin argues

Weekly Top Bonuses

Capitalcore

up to $2,500
deposit bonus for all clients

Your capital is at risk.

Top News

Olga Shendetskaya
14 hours ago

Digital euro gains momentum as Europe seeks payment independence

Digital euro gains momentum as Europe seeks payment independence

Hanna Syniavska
16 hours ago

Oracle workforce shrinks 13% over past year as AI push accelerates

Oracle workforce shrinks 13% over past year as AI push accelerates

Andrey Mastykin
18 hours ago

U.S. stock futures fall as investors pull back from tech shares

U.S. stock futures fall as investors pull back from tech shares

Igor Krasulya
19 hours ago

Meta takes minority stake in Indian fintech Cred

Meta takes minority stake in Indian fintech Cred

Olga Shendetskaya
20 hours ago

Oil market slips despite lingering risks around Iran deal

Oil market slips despite lingering risks around Iran deal

Top 5 companies for you

United States

Live News

Anton Kharitonov
Now

Goog;e pulls back as AI talent concerns pressure sentiment

Anton Kharitonov
Now

Apple pulls back below $300 as AI doubts offset strong fundamentals

Mykhailo Ihnatenko
Now

Tesla struggles below key resistance amid market uncertainty

Mykhailo Ihnatenko
Now

AMD faces rising correction risks despite AI sector optimism

Anton Kharitonov
Now

Bitcoin holds near $62,000 as weak risk appetite weighs

© IAFT Ltd., 2010-2026 All rights to the website are owned by IAFT Ltd.,
Registration number - HE 336186

Risk disclosure:

Information on the TradersUnion.com website is for informational purposes only and does not constitute any motive or suggestion to visitors to invest money. Moreover, we hereby warn you that trading on the Forex and CFD markets is always a high risk. According to the statistics, 75-89% of customers lose the funds invested and only 11-25% of traders earn a profit. Trading in futures and options carries substantial risk of loss and is not suitable for every investor.

That is why you should only invest money that you are prepared — or can afford — to lose at such high risks. Tradersunion.com does not provide any financial services, including investment or financial advisory services. Also, the Traders Union is not a broker and does not get money for trading in the Forex or CFD markets. Our website only provides information on brokers and the markets and helps its users to select the best brokerage company based on detailed information and objective analysis of brokers.
Disclaimer:

Traders Union (TradersUnion.com) shall not be liable for the consequences of trading decisions made by the Client and for the possible loss of his capital resulting from the use of this website and information published on it.

Forex market, CFD and cryptocurrency trading involves high risks and is not suitable for everyone. Before investing money, you need to adequately assess the level of your expertise and be aware of the risks, particularly in the context of trading with leverage. The information on this website is not intended for distribution or use by any person in any country or jurisdiction, where such distribution or use would be in violation of the local law or regulation. Any payments by Traders Union (TradersUnion.com) to the users of our website shall be legally interpreted solely as an incentive on our part for the activity on the website in the form of a deduction of a part of the advertising income; they shall not be a subject of any claims of our users or our obligations, a subject of disputes, as well as cannot be considered in relation to the services provided to users by brokers, both in fact and in their completeness and volume. The administration of the website shall not be liable for the content of user comments and reviews about the companies and shall not verify whether the authors of the reviews are indeed real clients of a specific company. All reviews, both negative and positive are published on the website without verification of their reliability; only offensive reviews that call for violence or any kind of discrimination and also reviews published from one group of IP addresses are moderated and removed. The authors of the materials shall be fully liable for the accuracy, completeness and impartiality of any information in the articles and reviews, including in the context of their use or mention of any brand names or trademarks. All mentions of the names of companies and their brands in any materials on the website shall be made in the context of communication of socially important information to the people about their activities by independent journalists, who are the authors. All evaluations and indicators on the website express the subjective opinion of the authors of the reviews (articles) and shall not be viewed as accurate statements and be a subject of disputes and claims against Traders Union.
Disclosure of advertisers and revenues:

All the services on the Tradersunion.com website are free for you to use. Our team spends thousands of hours per annum researching brokers and gathering information about them to help investors all over the world to choose reliable companies and to avoid fraudsters.

Indeed, the curating, sourcing, and organization of this process requires substantial financial investment by Tradersunion.com, which the website earns in the form of advertising payments. There are two types of advertising services on the website — direct advertising or partner (broker) participation programs. However, no services purchased by our partners shall affect the recommendations on our website, or our opinions, or ratings. Our ratings are based on our objective rating criteria and methodology; and the results are always equally and fairly applied to each broker. The work of our content authors and research groups does not involve any interaction with our advertisers and they do not have access to data concerning the amount of advertising purchased. For over 10 years we consider our independence, absolute openness, and objectivity as our main priority. Please follow the links to each of our affiliated broker’s websites. This will help Tradersunion.com to continue to provide our services to you for free.